Longitudinal Assessment of Transient Elastography in Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

141

Participants

Timeline

Start Date

March 8, 2017

Primary Completion Date

May 9, 2023

Study Completion Date

May 9, 2023

Conditions
Cystic Fibrosis Liver Disease
Interventions
PROCEDURE

Transient Elastography (TE)

Participants enrolled in Cystic Fibrosis Liver Disease Network (CFLD NET)Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis (PUSH) study in longitudinal follow up at centers with Fibroscan available (currently 8/11 centers)

Trial Locations (8)

30322

Children's Healthcare of Atlanta, Atlanta

45229

Cincinnati Children's Hospital Medical, Cincinnati

46202

Riley Hospital for Children, Indianapolis

60611

Ann & Robert H. Lurie Children's, Chicago

77030

Texas Children's Hospital, Houston

80045

Children's Hospital Colorado, Aurora

98105

Seattle Children's Hospital, Seattle

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT03001388 - Longitudinal Assessment of Transient Elastography in Cystic Fibrosis | Biotech Hunter | Biotech Hunter